Group I metabotropic glutamate receptors mediate a dual role of glutamate in T cell activation

Journal of Biological Chemistry

Volumn 279, Issue 32, 2004, Pages 33352-33358

  Pacheco, Rodrigo ^a   Ciruela, Francisco ^a   Casadó, Vicent ^a   Mallol, Josefa ^a   Gallart, Teresa ^a   Lluis, Carmen ^a   Franco, Rafael ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CALCIUM; CELLS; ENZYMES; NEUROLOGY; SIGNALING;

ADENYLATE; CYLASE; GLUTAMATE RECEPTORS; LYMPHOCYTES; PHOSPHOLIPASE;

BIOCHEMISTRY;

ADENYLATE CYCLASE; CALCIUM CHANNEL; CD3 ANTIGEN; CYCLIC AMP; GLUTAMATE 1 RECEPTOR; GLUTAMATE 5 RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMIC ACID; GLUTAMIC ACID DERIVATIVE; METABOTROPIC RECEPTOR 1; MITOGEN ACTIVATED PROTEIN KINASE 1; NEUROTRANSMITTER; PHOSPHOLIPASE C; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CELL PROLIFERATION; CELL STRAIN SKW6.4; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; LYMPHOID CELL LINE; NERVE CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

ANTIGENS, CD3; B-LYMPHOCYTES; CELL DIVISION; CELL LINE; CYCLIC AMP; GLUTAMIC ACID; HUMANS; JURKAT CELLS; LYMPHOCYTE ACTIVATION; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOLIPASE C; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, METABOTROPIC GLUTAMATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 4043114222     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.M401761200     Document Type: Article

References (22)

1. Ganor, Y., Besser, M., Ben-Zakai, N., Unger, T., and Levite, M. (2003) J. Immunol. 170, 4362-4372
2. Angelini, G., Gardella, S., Ardy, M., Ciriolo, M. R., Filomeni, G., Di Trapani, G., Clarke, F., Sitia, R., and Rubartelli, A. (2002) Proc. Natl. Acad. Sci. U. S. A. 99, 1491-1496
3. Nakanishi, S. (1992) Science 258, 597-603
4. Pin, J. P., and Duvoisin, R. (1995) Neuropharm. 34, 1-26
5. Pin, J. P., and Acher, F. (2002) Curr. Drug Targets CNS Neurol. Disord. 1, 297-317
6. Kostanyan, I. A., Merkulova, M. I., Navalotskaya, E. V., and Nurieva, R. I. (1997) Immunol. Lett. 58, 177-180
7. Storto, M., De Grazia, U., Battaglia, G., Felli, M. P., Maroder, M., Gulino, A., Ragona, G., Nicoletti, F., Screpanti, I., Frati, L., and Calogero, A. (2000) J. Neuroimmunol. 109, 112-120
8. Boyum, A. (1968) Scand. J. Clin. Lab. Invest. 21, 51-62
9. Kung, P., Goldstein, G., Reinhertz, E. L., and Schlossman, S. F. (1979) Science 206, 347-349
10. Van Wauwe, J. P., De Mey, J. R., and Goznes, J. G. (1980) J. Immunol. 124, 2708-2713
11. Ciruela, F., and McIlhinney, R. A. J. (1997) FEBS Lett. 418, 83-86
12. Mirabet, M., Mallol, J., Lluis, C., and Franco, R. (1997) Br. J. Pharmacol. 122, 1075-1082
13. Francesconi, A., and Duvoisin, R. M. (1998) J. Biol. Chem. 273, 5615-5624
14. Winder, D. G., and Conn, P. J. (1993) J. Neurosci. 13, 38-44
15. Ramstad, C., Sundvold, V., Johansen, H. K., and Lea, T. (2000) Cell. Signal. 12, 557-563
16. Torgersen, K. M., Vang, T., Abrahamsen, H., Yaqub, S., and Tasken, K. (2002) Cell. Signal. 14, 1-9
17. Lombardi, G., Dianzani, C., Miglio, G., Canonico, P. L., and Fantozzi, R. (2001) Br. J. Pharmacol. 133, 936-944
18. Tsai, P. J., and Huang, P. C. (1999) Metabolism 48, 1455-1460
19. Divino Filho, J. C., Hazel, S. J., Furst, P., Bergstrom, J., and Hall, K. (1998) J. Endocrinol. 156, 519-527
20. Dale, L. B., Badwah, A. V., and Ferguson, S. S. G. (2002) Neurochem. Int. 41, 319-326
21. Sorensen, S. D., and Conn, P. J. (2003) Neuropharmacology 44, 699-706
22. Arslan, G., Kull, B., and Fredholm, B. B. (2002) Naunyn-Schmiedebergs Arch. Pharmakol. 365, 150-157